Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Endoglim Trio 2.3 Tablet SR

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Endoglim Trio 2.3 Tablet SR

Triginta 2.3 SR tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. This medication helps manage blood glucose in diabetic patients. Triginta 2.3 SR tablets must be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels, potentially leading to kidney damage, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive program including diet, exercise, and weight management as directed by your doctor; lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect; learn its symptoms (sweating, dizziness, headache, tremors) and management. Maintain regular meals and carry a readily available fast-acting glucose source, such as sugary snacks or juice. Alcohol consumption increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your physician of any history of heart disease before commencing treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should seek medical advice prior to use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function are necessary.

Primary Ingredients of Endoglim Trio 2.3 Tablet SR

The provided text is "undefined," which lacks meaning and cannot be rephrased. A rephrased version would also be undefined.

Uses of Endoglim Trio 2.3 Tablet SR

Managing type 2 diabetes

Major Benefits of Endoglim Trio 2.3 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Endoglim Trio 2.3 Tablet SR on an empty stomach.

Common Side effects of Endoglim Trio 2.3 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Endoglim Trio 2.3 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Endoglim Trio 2.3 Tablet SR on an empty stomach.

How Endoglim Trio 2.3 Tablet SR works:

Endoglim Trio 2.3 extended-release tablets contain a triple combination of antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Endoglim Trio 2.3 Tablet SR and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Endoglim Trio 2.3 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Endoglim Trio 2.3 mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Endoglim Trio 2.3 SR tablets is likely contraindicated in individuals with impaired kidney function and should be avoided. Medical advice is recommended. Furthermore, this medication is not advised for patients exhibiting severe renal dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Endoglim Trio 2.3 SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiating treatment with a low dose of Endoglim Trio 2.3 SR tablets is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Endoglim Trio 2.3 Tablet SR :

Should you forget a dose of Endoglim Trio 2.3 SR Tablet, ingest it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Endoglim Trio 2.3 Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Endoglim Trio 2.3 Tablet SR

Endoglim Trio 2.3 SR tablets contain glimepiride, metformin, and voglibose, working synergistically to manage type 2 diabetes mellitus in adults. This regimen enhances glycemic control when coupled with a suitable diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and improves insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, specifically reduces post-meal blood sugar elevations. This formulation is unsuitable for treating type 1 diabetes.
Taking Endoglim Trio 2.3 SR tablets may lead to common adverse events such as low blood sugar, queasiness, loose stools, changes in taste perception, gas, abdominal discomfort, headache, skin eruptions, and respiratory illness.
Patients with hypersensitivity to Endoglim Trio 2.3 Tablet SR constituents or inactive ingredients should not use this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel conditions, colonic ulcers, and metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol concurrently with Endoglim Trio 2.3 Tablet SR is inadvisable. This combination may lead to dangerously low blood glucose and heighten the risk of lactic acidosis.
Endoglim Trio 2.3 Tablet SR can indeed lower blood sugar, potentially causing hypoglycemia. Low blood sugar symptoms may include nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with missed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry a readily available source of glucose, such as glucose tablets, honey, or fruit juice.
Retain this medication within its original, sealed packaging. Follow the storage guidelines printed on the package or label. Discard any leftover medication. Prevent access by children, pets, and others.
Endoglim Trio 2.3 Tablet ...
126
MRP 154
18% off